Targeting the ACE2 and Apelin Pathways Are Novel Therapies for Heart Failure: Opportunities and Challenges by Seyyed M. R. Kazemi-Bajestani, Vaibhav B. Patel, Wang Wang, Gavin Y. Oudit

Get full text

Early genetic screening and cardiac intervention in patients with cardiomyopathies in a multidisciplinary clinic by Chandu Sadasivan, Luke R. Gagnon, Deepan Hazra, Kaiming Wang, Erik Youngson, Jissy Thomas, Anita Y.M. Chan, D. Ian Paterson, Finlay A. McAlister, Tara Dzwiniel, Wayne Tymchak, Susan Christian, Gavin Y. Oudit

Get full text

Device Therapy in Patients with Heart Failure: Is Medication Use Optimized and Are We Targeting Those Patients Most Likely to Benefit? by Robert Wannamaker, MD, MSc, Roopinder K. Sandhu, MD, MPH, Justin A. Ezekowitz, MBBCh, MSc, Sheri L. Koshman, PharmD, Derek S. Chew, MD, MSc, Luke R. Gagnon, MD, MSc, Chen-Hsiang Ma, MD, Chandu Sadasivan, Gavin Y. Oudit, MD, PhD, Finlay A. McAlister, MD, MSc

Get full text

DG9 boosts PMO nuclear uptake and exon skipping to restore dystrophic muscle and cardiac function by Md Nur Ahad Shah, Harry Wilton-Clark, Farhia Haque, Brooklynn Powell, Laura Edellein Sutanto, Radha Maradiya, Pavel Zhabyeyev, Rohini Roy Roshmi, Saeed Anwar, Tejal Aslesh, Kenji Rowel Q. Lim, Rika Maruyama, Anne Bigot, Courtney S. Young, Scott Bittner, Melissa J. Spencer, Hong M. Moulton, Gavin Y. Oudit, Toshifumi Yokota

Get full text